SCHEMBL1364488

SCHEMBL1364488

Cc1c(N[C@@H](C(=O)NNC(=O)c2cccc(O)c2)[C@@H](C)O)ccc(C#N)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.41
PGR P06401 2/20 0.40
AKR1C4 P17516 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
NR3C1 P04150 1/20 0.35
METAP2 P50579 2/20 0.35
METAP1 P53582 2/20 0.35
POLB P06746 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CXCR1 P25024 1/20 0.34
CXCR2 P25025 1/20 0.34
KDM4E B2RXH2 1/20 0.34
EGLN2 Q96KS0 1/20 0.34
GAA P10253 2/20 0.34
S1PR3 Q99500 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1362965 1.00 AR (0.41) ARPGRAKR1C4AKR1C3AKR1C2
SCHEMBL1364617 0.92 METAP2 (0.43) ARPGRMETAP2METAP1GAA
SCHEMBL1364542 0.91 NPC1 (0.41) ARPGRPOLBNPC1RAB9A
SCHEMBL12140544 0.91 NPC1 (0.41) ARPGRPOLBNPC1RAB9A
SCHEMBL1364613 0.90 AR (0.43) ARPGRNR3C1CXCR1CXCR2
SCHEMBL1365319 0.90 AR (0.43) ARPGRNR3C1CXCR1CXCR2
SCHEMBL15663246 0.90 NPC1 (0.45) ARPGRPOLBNPC1RAB9A
SCHEMBL1364981 0.90 NPC1 (0.45) ARPGRPOLBNPC1RAB9A
SCHEMBL12342007 0.89 RAB9A (0.34) AKR1C4AKR1C3AKR1C2AKR1C1METAP2
SCHEMBL12140296 0.89 RAB9A (0.34) AKR1C4AKR1C3AKR1C2AKR1C1METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2260028-B1 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH INC (US) 2014-05-07 EP disclosed
US-8629167-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2014-01-14 US disclosed
US-8629167-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2014-01-14 US disclosed
US-8455525-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2013-06-04 US disclosed
US-8455525-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2013-06-04 US disclosed
US-20130116288-A1 Selective Androgen Receptor Modulators RADIUS HEALTH, INC. (US) 2013-05-09 US disclosed
US-20130116288-A1 Selective Androgen Receptor Modulators RADIUS HEALTH, INC. (US) 2013-05-09 US disclosed
US-8268872-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2012-09-18 US disclosed
US-8268872-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2012-09-18 US disclosed
US-8067448-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2011-11-29 US disclosed
US-8067448-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2011-11-29 US disclosed
US-20110224267-A1 Selective androgen receptor modulators Radius Health,Inc. (US) 2011-09-15 US disclosed
US-20110224267-A1 Selective androgen receptor modulators Radius Health,Inc. (US) 2011-09-15 US disclosed
US-20100041721-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH, INC. (US) 2010-02-18 US disclosed
US-20100041721-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH, INC. (US) 2010-02-18 US disclosed
US-20090253758-A1 Selective androgen receptor modulators ELLIPSES PHARMA LTD (GB) 2009-10-08 US disclosed
US-20090253758-A1 Selective androgen receptor modulators ELLIPSES PHARMA LTD (GB) 2009-10-08 US disclosed
WO-2009105214-A2 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH, INC. (US) 2009-08-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041721-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS AR, SHBG, IGF1R AR 1/4885PGR 16/4885AKR1C4 133/4885
US-20110224267-A1 Selective androgen receptor modulators AR, SHBG, GPR119 AR 1/4885PGR 28/4885AKR1C4 154/4885
US-20130116288-A1 Selective Androgen Receptor Modulators AR, SHBG, IGF1R AR 1/4885PGR 17/4885AKR1C4 124/4885
US-20090253758-A1 Selective androgen receptor modulators AR, SHBG, GPR119 AR 1/4885PGR 28/4885AKR1C4 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.